Eric Claassen 教授演讲的内容引起了与会专家广泛的兴趣,在演讲结束后他与许多医生关于肠道微生态平衡及微生态制剂的使用等问题进行了充分的交流。他希望将国外使用多菌种微生态制剂的先进经验分享给中国的医生与患者。相信随着我国对于微生态或者多菌种益生菌制剂了解和研究的深入,它必将在维护我们肠道健康方面发挥越来越重要的作用。
参考文献
[1] Koning, C. J. et al. The effect of a multispecies probiotic on the intestinal microbiota and bowel movements in healthy volunteers taking the antibiotic amoxycillin. Am J Gastroenterol 103, 178-189 (2008).
[2] Lang, F. C. Use of a multi-species probiotic: For the prevention of antibiotic associated diarrhea. NUTRA foods 9, 27-31 (2010).
[3] Guidelines, W. G. O. G. WGO Global Guideline Probiotics and prebiotics. (2017).
[4] Qazi, T. et al. The risk of inflammatory bowel disease flares after fecal microbiota transplantation: Systematic review and meta-analysis. Gut Microbes 8, 574-588 (2017).
[5] Saskia van Hemert, J. V., Burkhard Schütz. Clinical Studies Evaluating Effects of Probiotics on Parameters of Intestinal Barrier Function. Advances in Microbiology 3, 212-221 (2013).
[6] Persborn, M. et al. The effects of probiotics on barrier function and mucosal pouch microbiota during maintenance treatment for severe pouchitis in patients with ulcerative colitis. Aliment Pharmacol Ther 38, 772-783 (2013).
[7] Larsen, O. F. A. & Claassen, E. The mechanistic link between health and gut microbiota diversity. Sci Rep 8, 2183 (2018).